Hydroxychloroquine and remdesivir not effective in covid-19 treatment: WHO


Posted on 17th Oct 2020 03:29 pm by rohit kumar

The World Health Organization has identified four drugs, including remadecivir and hydroxychloroquine (HCQ), to be much less effective in treating corona virus-infected patients.

 

The World Health Organization (WHO) conducted a detailed test on how effective four particular drugs are in the treatment of Covid-19.

 

Remadecivir was the first drug that was first used to treat the coronavirus. This drug was also recently used in the treatment of US President Donald Trump.

 

Gilead, the maker of Remedesivir, has rejected the results of the WHO study.

 

Gilead issued a statement saying that the findings of the study do not match those of other studies and these results are yet to be reviewed.

 

WHO SAYS WHO'S STUDY

 

The WHO tested a total of four drugs during the Solidarity trial. Including remdesivir , hydroxychloroquine, auto-immune drug interferon, and a combination of HIV drugs lopinavir and ritonavir.

 

The low-cost steroid dexamethasone used in the treatment of severe Covid-19 patients in Britain has not been included in this study.

 

These four drugs were tested in 11,266 adult patients in 500 hospitals in 30 different countries.

 

WHO results have found that these drugs have not proved effective in saving patients' lives and also reducing the days of infection. However, these results are yet to be reviewed.

 

WHO Chief Scientist Soumya Swaminathan said on Wednesday that the testing of hydroxychloroquine and lopinavir and ritonavir was stopped in June as they had already proved ineffective. However, tests on other drugs were continued.

 

The results of the World Health Organization are completely different from the results of Gilead's study last month. Gilead had said that the time to recover from comrades virus is reduced by five days compared to patients given placebo. Gilead's trial involved 1000 patients.

 

Gilead's response

 

Gilead Sciences has dismissed the WHO results, saying, "This data looks inconsistent." The benefits of remdesivir are evidenced by more concrete evidence from academic and controlled studies published in several journals.

 

"We are concerned that this open (open) labeled global test data has not gone through rigorous review, which is necessary for such useful scientific discussion."

 

In the United States, the use of remdesivir has been allowed in an emergency from May 1. After this, its use was also approved in many other countries.

 

At the same time, hydroxychloroquine is used on the instructions of the doctor to protect against coronavirus infection. However, there is no clear evidence of how effective it is.

 

Looking at these results, Dr. Swaminathan says, "We are considering monoclonal antibodies and some new anti-viral drugs that have been developed in the last few months."

1 Like 0 Dislike
Previous news Next news
Other news

Big change on Co-Win regarding vaccination, now four-digit security code will be available

A rapid vaccination campaign is going on in the country for the prevention of the coronavirus. Mi

'Where was it said that we will mix it in the soil' BJP gadgad from the encounter of Usman who was involved in Umesh Pal murder case

Another shooter involved in the Umesh Pal murder case was killed by the police in an encounter on

Weather Update: From Kashmir to the South, the weather changed its course, and temperature may increase in different parts

The weather has changed its course in India. In most parts of the country, day temperature has be

Emmanuel Macron On PM Modi: 'PM Modi was right', why did French President Emmanuel Macron say this in the UN? Know the whole matter

UN General Assembly: French President Emmanuel Macron praised the Prime Minister of India, Narend

In the case in which Daler Mehndi was arrested, more than 30 cases were registered

Punjab's Patiala Court has upheld the two-year sentence awarded to famous Punjabi singer Daler Me

Weather News Today: Haze in Delhi-NCR, rain alert in UP-Bihar, know - latest weather updates

Rains are continuing in many parts of the country. From Delhi-NCR to UP-Bihar in October, the rai

Delhi Service Bill: 'BJP is jealous of Kejriwal's good work', Sanjay Raut's sarcasm on Center regarding Delhi Service Bill

With the Delhi Services Bill set to be tabled in the Rajya Sabha on Monday, the Congress and the

Delhi Flood: Yamuna's water level decreased but danger remains, Yamuna is still flowing 2 meters above the danger mark

The flow of Yamuna is continuously decreasing. Now the water level has come down to 208 meters, b

India has the potential to become a world leader in footwear, and leather: Piyush Goyal

Union Commerce and Industry Minister Piyush Goyal said on Tuesday that India has the potential to

When will the schools open: The process of unlocking begins, know when the schools will start in these 7 states

Keeping in view the circumstances arising due to corona infection in the country, various restric

Sign up to write
Sign up now if you have flare of writing..
Login   |   Register
Follow Us
Indyaspeak @ Facebook Indyaspeak @ Twitter Indyaspeak @ Pinterest RSS



Play Free Quiz and Win Cash